1,488
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Comparing the effectiveness of biological disease-modifying antirheumatic drugs using real-world data

, &
Pages 87-97 | Received 14 Dec 2017, Accepted 14 Feb 2018, Published online: 02 Aug 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (6)

Fumihiko Ando, Katsuhiko Takabayashi, Shinsuke Fujita, Hiroshi Nakajima, Hideki Hanaoka & Takahiro Suzuki. (2023) Seasonal exacerbation of rheumatoid arthritis detected by big claims data analysis: A retrospective population study. Modern Rheumatology 33:1, pages 46-53.
Crossref
Ashley Fletcher, Marissa Lassere, Lyn March, Catherine Hill, Claire Barrett, Graeme Carroll & Rachelle Buchbinder. (2022) Patterns of biologic and targeted-synthetic disease-modifying antirheumatic drug use in rheumatoid arthritis in Australia. Rheumatology 61:10, pages 3939-3951.
Crossref
Katsuhiko Takabayashi, Fumihiko Ando, Kei Ikeda, Shinsuke Fujita, Hiroshi Nakajima, Hideki Hanaoka & Takahiro Suzuki. (2022) Trend in prescription and treatment retention of molecular-targeted drugs in 121,131 Japanese patients with rheumatoid arthritis: A population-based real-world study. Modern Rheumatology 32:5, pages 857-865.
Crossref
Sei Muraoka, Zento Yamada, Mai Kawazoe, Wataru Hirose, Hajime Kono, Shinsuke Yasuda, Yukiko Komano, Hiroshi Kawano, Toshihiko Hidaka, Shusaku Nakashima, Tsuyoshi Kasama, Tamio Teramoto & Toshihiro Nanki. (2021) Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational Study. Rheumatology and Therapy 8:4, pages 1585-1601.
Crossref
Marisol Samartín-Ucha, Jose Maria Pego-Reigosa, Miriam Álvarez-Payero, Alicia Martin-Vila, Guadalupe Pineiro-Corrales, Maria Rodriguez-Rodriguez, Rafael Benito Melero-Gonzalez, Francisco Maceiras-Pan, Cristina Martinez-Reglero & Noemi Mrtinez-Lopez de Castro. (2021) Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study. European Journal of Hospital Pharmacy 28:e1, pages e47-e50.
Crossref
Takayasu Ando, Takeshi Suzuki, Yutaka Gotou, Mitsuru Imamura, Hiroko Nagafuchi, Yoshioki Yamasaki, Seido Ooka & Kimito Kawahata. (2019) Early Response of DAS28-ESR (3) Predicts Sustained Response to Tocilizumab Switched from Abatacept. Journal of St. Marianna University 10:2, pages 39-49.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.